Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NAUT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Forecast
2026-Revenue
-450%2026-EPS
2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
Guggenheim
initialisePrevious: Not converted
2024-06-27
Now: Buy
Jefferies
downgradePrevious: Not converted
2024-06-03
Now: Hold
Zacks Investment Research
downgradePrevious: Not converted
2022-04-26
Now: Sell
Quote Panel
Key Metrics
https://www.defenseworld.net
3 hours ago
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
seekingalpha.com
13 hours ago
seekingalpha.com
16 hours ago
seekingalpha.com
18 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
-0.13
vs -0.11
Q4.23
N/A
-0.14
vs -0.11
Q1.24
N/A
-0.15
vs -0.12
Q2.24
N/A
-0.14
vs -0.13
Q3.24
N/A
-0.13
vs -0.13
Q4.24
N/A
-0.14
vs -0.14
Q1.25
N/A
-0.13
vs -0.15
Q2.25
N/A
-0.12
vs -0.14
Q3.25
N/A
-0.15
vs -0.13
Q4.25
N/A
-0.15
vs -0.14
Sales Growth
YoY
Current
Estimates
Q3.23
NA
NA vs NA
Q4.23
NA
8.2M vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
-100%
NA vs 8.2M
Q1.25
NA
NA vs NA
Q2.25
NA
NA vs NA
Q3.25
NA
500K vs NA
Q4.25
NA
1.3M vs NA
Return on Equity
QoQ
Q1.23
-5%
-0.05
vs -0.04
Q2.23
-5%
-0.05
vs -0.05
Q3.23
-6%
-0.06
vs -0.05
Q4.23
-6%
-0.06
vs -0.06
Q1.24
-8%
-0.08
vs -0.06
Q2.24
-8%
-0.08
vs -0.08
Q3.24
-7%
-0.07
vs -0.08
Q4.24
-8%
-0.08
vs -0.07
Q1.25
-9%
-0.09
vs -0.08
Q2.25
-8%
-0.08
vs -0.09
Institutionnal Ownership
QoQ
Q4.22
79
79
vs 83
-5%
Q1.23
78
78
vs 79
-1%
Q2.23
77
77
vs 78
-1%
Q3.23
77
77
vs 77
NA
Q4.23
77
77
vs 77
NA
Q1.24
72
72
vs 77
-6%
Q2.24
77
77
vs 72
7%
Q3.24
83
83
vs 77
8%
Q4.24
87
87
vs 83
5%
Q1.25
88
88
vs 87
1%
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.01 ( -1.77%)
After-hours 0.71$
0.01 (2.14%)
Relative Strenght
4
Volume Buzz
-47%
Earning Acce
Yes
Dist 52w H.
77%Relative Strength
NAUT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|